We found that both DNMT3A and TET2 germline deleterious mutations were significantly associated with PAH in European individuals, and that several additional cases contained splice variants and CHIP mutations in these genes [46]. The gene discussed is DNMT3A; the disease is pulmonary arterial hypertension.